copper sulfate has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupte, A; Mumper, RJ | 1 |
| Chen, J; Du, C; Kang, J; Wang, J | 1 |
2 other study(ies) available for copper sulfate and Leukemia
| Article | Year |
|---|---|
Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Copper Sulfate; HL-60 Cells; Humans; Hydrogen Peroxide; Leukemia; Penicillamine; Reactive Oxygen Species; Sulfhydryl Compounds | 2007 |
Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
Topics: Acetylation; Apoptosis; Butyrates; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Copper; Copper Sulfate; Enzyme Inhibitors; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; HL-60 Cells; Humans; Hydroxamic Acids; Leukemia; Phenanthrolines; Pyrrolidines; Thiocarbamates | 2008 |